PEP/NEWS — Peptide intel. Daily.

BPC-157 AND TB-500 TARGET COMPLEMENTARY HEALING PATHWAYS — ACTIN DYNAMICS VS NITRIC OXIDE SIGNALINGRETATRUTIDE PHASE 2 DATA SHOWED GREATER WEIGHT LOSS THAN TIRZEPATIDE AT MATCHED TIMEPOINTSUNDER 7 HOURS OF SLEEP RANKS 3RD STRONGEST PREDICTOR OF EARLY DEATH IN US COUNTY-LEVEL DATAGLP-1 RECEPTOR AGONISTS NOW FLAGGED IN PRE-SURGICAL SCREENING FOR DELAYED GASTRIC EMPTYING RISKDASATINIB + QUERCETIN REMAINS THE ONLY SENOLYTIC COMBINATION TESTED IN HUMAN CLINICAL TRIALSCREATINE SUPPLEMENTATION ENHANCED POWER TRAINING OUTCOMES IN OLDER ADULTS BEYOND EXERCISE ALONEEPIGENETIC CLOCKS BUILT FROM IMMUNE CELL METHYLATION DATA SHOW WEAK CORRELATION WITH PHYSICAL FITNESS LEVELSKHAVINSON EPITALON RESEARCH PROGRAM SPANS 40+ YEARS AND INCLUDES BOTH ANIMAL AND LIMITED HUMAN LONGEVITY DATA BPC-157 AND TB-500 TARGET COMPLEMENTARY HEALING PATHWAYS — ACTIN DYNAMICS VS NITRIC OXIDE SIGNALINGRETATRUTIDE PHASE 2 DATA SHOWED GREATER WEIGHT LOSS THAN TIRZEPATIDE AT MATCHED TIMEPOINTSUNDER 7 HOURS OF SLEEP RANKS 3RD STRONGEST PREDICTOR OF EARLY DEATH IN US COUNTY-LEVEL DATAGLP-1 RECEPTOR AGONISTS NOW FLAGGED IN PRE-SURGICAL SCREENING FOR DELAYED GASTRIC EMPTYING RISKDASATINIB + QUERCETIN REMAINS THE ONLY SENOLYTIC COMBINATION TESTED IN HUMAN CLINICAL TRIALSCREATINE SUPPLEMENTATION ENHANCED POWER TRAINING OUTCOMES IN OLDER ADULTS BEYOND EXERCISE ALONEEPIGENETIC CLOCKS BUILT FROM IMMUNE CELL METHYLATION DATA SHOW WEAK CORRELATION WITH PHYSICAL FITNESS LEVELSKHAVINSON EPITALON RESEARCH PROGRAM SPANS 40+ YEARS AND INCLUDES BOTH ANIMAL AND LIMITED HUMAN LONGEVITY DATA

Last updated May 18, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Lifespan.io
GLP-1 DRUGS DON'T STEAL YOUR MUSCLE — NEW DATA CHALLENGES THE NARRATIVE...

*New study finds GLP-1 receptor agonists lose no more muscle than plain caloric restriction.*

Lifespan.io

Featured Briefs

◤ Article

SENOLYTIC RESEARCH IN 2026: WHERE THE FIELD ACTUALLY STANDS...

Senescent cells — cells that stop dividing but keep pumping out inflammatory signals — are a confirmed driver of aging. Fight Aging! maps where the clinical trials are now, and why only one combination (dasatinib + quercetin) has reached human trials. The gap between animal data and the clinic remains wide.

Fight Aging!
◤ Article

CYCLARITY PHASE 1 TRIAL: TOXIC CHOLESTEROL CLEARED FROM PLAQUES...

Cyclarity Therapeutics just released Phase 1 data showing its compound UDP-003 can pull 7-ketocholesterol (a toxic oxidized form of cholesterol) out of macrophages and soft plaques. Most cardiovascular drugs slow the disease — this one targets an upstream root cause. Early data, but the mechanism is distinct.

Lifespan.io
▶ Video

HOW TO OVERCOME SOCIAL ANXIETY | DR. NICK EPLEY

Dr. Nick Epley, PhD, is a professor of behavioral science at the University of Chicago and a leading expert on the science of social connection. We discuss how seemingly small daily interactions with strangers (as well as with people we kno

Andrew Huberman
▶ Video · Peptide-anchored

HOW OFTEN TO TAKE MOTS-C

Are you taking MOTS-c too often and missing the biological rhythm your mitochondria actually need for better energy, fat metabolism, and performance? In this video, I break down how MOTS-c works through AMPK activation, mitochondrial biogen

Regan Archibald
▶ Video

COPY THIS EXACT DAY TO LOSE 30 POUNDS BY SUMMER!

Summer is closer than you think — and if you want to look and feel completely different by the time it gets here, the window to make it happen is right now. In this video, I walk you through a complete day-by-day protocol, from the moment y

Dr Livingood

More Headlines